Netherlands - Events
The Marcus Evans 16th Edition R&D Controlling and Performance Management conference taking place in Amsterdam, Netherlands on 16-18 March, 2026 will tackle into some of the toughest challenges R&D controllers face today: securing funding for projects with uncertain outcomes, making the intangible value of innovation visible, and balancing transparency with the freedom researchers need to create. This conference will guide you through practical tools and real scenarios to transform uncertainty into actionable choices. You’ll learn how to build flexible budgets that withstand change, translate innovation into business value executives can back, and confidently sell R&D as a strategic growth driver.
Attending this premier Marcus Evans conference will enable you to:• Win the…
Europe's oligonucleotide landscape is entering a pivotal growth phase. With the €21M launch of Aerska and major collaborations such as Novartis and SciNeuron, Lundbeck and Contera, and Secarna and Vect-Horus, European biopharma are rapidly advancing RNA-targeted approaches to address previously undruggable CNS diseases.
In response to this momentum, the inaugural Oligonucleotides for CNS Summit Europe will unite 60+ senior industry leaders for the first European forum dedicated exclusively to CNS-focused Oligonucleotide therapeutics.
The summit delivers three days of highly technical, data-driven discussions addressing the challenges unique to CNS development with insight into next-generation BBB delivery strategies beyond TfR1, advanced in vivo and iPSC models, novel chemistry…
